- Home
- WAT vs ESS Comparison
WAT vs ESS Comparison
Compare WAT & ESS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAT
- ESS
- Stock Information
- Founded
- WAT 1958
- ESS 1971
- Country
- WAT United States
- ESS United States
- Employees
- WAT N/A
- ESS N/A
- Industry
- WAT Biotechnology: Laboratory Analytical Instruments
- ESS Real Estate Investment Trusts
- Sector
- WAT Industrials
- ESS Real Estate
- Exchange
- WAT Nasdaq
- ESS Nasdaq
- Market Cap
- WAT 17.4B
- ESS 16.9B
- IPO Year
- WAT 1995
- ESS 1994
- Fundamental
- Price
- WAT $387.37
- ESS $262.14
- Analyst Decision
- WAT Buy
- ESS Hold
- Analyst Count
- WAT 13
- ESS 18
- Target Price
- WAT $379.00
- ESS $293.91
- AVG Volume (30 Days)
- WAT 637.6K
- ESS 572.7K
- Earning Date
- WAT 11-04-2025
- ESS 10-29-2025
- Dividend Yield
- WAT N/A
- ESS 3.93%
- EPS Growth
- WAT 3.82
- ESS 53.64
- EPS
- WAT 10.88
- ESS 13.15
- Revenue
- WAT $3,105,638,000.00
- ESS $1,916,711,000.00
- Revenue This Year
- WAT $7.12
- ESS $4.02
- Revenue Next Year
- WAT $6.22
- ESS $3.80
- P/E Ratio
- WAT $35.50
- ESS $19.91
- Revenue Growth
- WAT 6.90
- ESS 9.37
- 52 Week Low
- WAT $275.05
- ESS $243.25
- 52 Week High
- WAT $423.56
- ESS $316.29
- Technical
- Relative Strength Index (RSI)
- WAT 77.28
- ESS 54.23
- Support Level
- WAT $340.09
- ESS $256.01
- Resistance Level
- WAT $382.02
- ESS $261.51
- Average True Range (ATR)
- WAT 10.44
- ESS 5.91
- MACD
- WAT 2.22
- ESS 0.83
- Stochastic Oscillator
- WAT 99.09
- ESS 81.20
About WAT Waters Corporation
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.
About ESS Essex Property Trust Inc.
Essex Property Trust owns a portfolio of 258 apartment communities with over 62,000 units. The company focuses on owning large, high-quality properties on the West Coast in the urban and suburban submarkets of Southern California, Northern California, and Seattle.